cagrilintide peptide with retatrutide dosage - Pure Tested Peptides Cagrilintide + Retatrutide (Reta) Peptide
Description
Laukkanen T, Khan H, Zaccardi F, Laukkanen JA
Intramuscular injection delivers absolute bioavailability between 14 to 20% compared to intravenous dosing
It is a dual GLP-1 and GIP receptor agonist, meaning it activates two incretin hormone pathways simultaneously
doi: 10.1073/pnas.89.10.4678
